INTRODUCTION
There is clear evidence that herpes simplex virus (HSV) establishes latency in neuronal cells of the mouse; reactivation of latent virus takes place following explantation of ganglia from neurons with the production of infectious virus (Cook et al., 1974; McLennan & Darby, 1980; Kennedy et al., 1983) . Although the question of whether latency can be established at non-neural sites has been addressed by several groups, in general HSV has not been recovered from peripheral tissue of the mouse at the site of inoculation (for review, see Wildy et al., 1982; Hill, 1985) . As a consequence it has become widely accepted that HSV latency can only be established in nervous tissue, particularly the neurons of the dorsal root ganglia (DRG). Hill et al. (1980) reported the successful isolation of HSV type 1 (HSV-1) from organ cultures of ear skin (the site of inoculation) in 8 ~ to 9 ~ of latently infected mice and suggested that this infectious virus originated from the primary site of latency, the sensory ganglion. More recently, HSV-1 and HSV type 2 (HSV-2) wild-type (wt) virus and temperature-sensitive (ts) mutants have regularly been recovered after explantation and cultivation of the skin of the inoculated footpad (FP) as well as from the DRG of mice 3 months or more after inoculation of virus into the FP (A1- Saadi et al., 1983; Clements & Subak-Sharpe, 1983; Subak-Sharpe et aL, 1984a, b) .
HSV-2 and HSV-I have been recovered from the skin at the site of inoculation (FP, vagina) in guinea-pigs (Scriba, 1976 (Scriba, , 1977 (Scriba, , 1981 Donnenberg et al., 1980) . However, the guinea-pig frequently undergoes episodes of clinically apparent recurrent disease in the FP after infection with HSV; and in this system virus can usually be isolated from the explanted FP skin immediately or within the first few days in culture. Such virus could originate either from latently infected neurons in DRG following reactivation or alternatively from latent or persistent infection in the FP.
Our previous studies using five different strains of mouse have provided strong evidence suggesting that in addition to the DRG, HSV-I and HSV-2 can establish genuine latency within cells of mouse FP tissue (AI-Saadi et al., 1983; Clements & Subak-Sharpe, 1983; Subak-Sharpe et al., 1984a, b; A1-Saadi, 1984) . Infectious virus has never been detected in mouse FP tissue at the time of explantation or within the first 6 days following explantation, but after more prolonged culture infectious virus does become detectable. We now report that neither prolonged treatment of latently infected mice with acycloguanosine (ACG), nor section of the sciatic and femoral nerves of the inoculated leg, nor nerve section and ACG treatment combined, prevent the recovery of HSV from the FP following explantation and culture.
METHODS
Mice. The BALB/c mice used were bred on site; after initial brothe~sister mating for four generations they were maintained as a randomly bred closed colony.
Virus. HSV-2 wt strain HG52 and the ts mutants 3 and 4 derived from it were used (Timbury, 1971) . The core body temperature of the mouse is 38-5 °C. The non-permissive temperature for growth of these mutants is 38-5 °C.
Virus was propagated by infection of BHK 21/C13 (C13) cells in roller bottles at an m.o.i, of I p.f.u./300 cells. Virus was allowed to absorb at 31 °C for 30 to 45 min, then 25 ml of Glasgow modified Eagle's medium (MEM) was added, supplemented with 10% (v/v) tryptose phosphate broth and 10% calf serum. The infected cultures were incubated at 31 °C for at least 3 days or until an extensive c.p.e, was observed. Cells were then harvested, centrifuged at 500 g for l0 min at 4 °C and resuspended in 5 ml of supernatant fluid. The suspension was sonicated for 2 to 3 min to release cell-associated virus and centrifuged at 500g for l0 min. The supernatant was then poured off and stored. The sonication procedure was repeated on the resuspended pellet and the supernatants were pooled and assayed for infectious virus by titration at 31 °C or 38-5 °C on Cl 3 cell monolayers cultured in Eagle's medium with 10~ calf serum supplemented with 5% human serum in 30 mm Petri dishes. Cultures were fixed and stained with Giemsa stain on the second or third day after infection and the plaques counted. Both ts mutants had a titre of l0 6 p.f.u./ml or greater at 31 °C. In the case of is3 no plaques were present at 38-5 °C while ts4 had less than 100 p.f.u./ml at 38-5 °C.
Mouse inoculation. This has been described previously (AI-Saadi et al., 1983; Clements & Subak-Sharpe, 1983 ). Both male and female mice were used; they were inoculated subcutaneously at weaning (3 to 4 weeks) into the right rear FP; 0.025 ml of virus suspended in phosphate-buffered saline with 10% calf serum was the inoculum. The virus inoculum was titrated on C13 cells at 31 °C and 38-5 °C at the time of inoculation. Mice were examined daily for the first 3 weeks after inoculation for the presence of clinically detectable lesions.
ACG treatment. Six weeks after inoculation each litter was divided into two equal groups apportioning males and females evenly. In the first experimental group of animals (data presented in Table 2 ) one half litter (control) was provided with tap water, the other (experimental) half was provided with tap water containing 0.5 g/l ACG (2.5 mM) ad libitum, otherwise the two groups were treated in exactly the same fashion. The ACG was kindly supplied by Dr P. Collins of Wellcome Research Laboratories, Beckenham, U.K. After a further 6 weeks (i. e. at 12 weeks post-inoculation) mice were killed and dissected. For the last 2 days prior to dissection mice treated with ACG were transferred back to tap water without drug. In subsequent experiments ACG treatment was continued until the mice were killed and dissected and the level of ACG was increased to 1-0 g/l (0-5 mM). Throughout the experimental period each mouse drank approximately 2 to 3 ml of water per day; the intake of ACG was approximately I mg/mouse/day at 0-5 g/1 giving a dose of approximately 40 mg/kg (80 mg/kg at 1.0 g/l). There was no significant difference in water consumption between the control and experimental groups.
Nerve section. Twelve weeks after virus inoculation both femoral and sciatic nerves on the right were sectioned under intraperitoneal methobexitone anaesthesia (0-15 to 0.3 mg/mouse). Untreated and mock-operated animals were studied in parallel. Mice were kept for l to 2 weeks following the operation and then killed and the lumbar and sacral DRG and the FP tissue from both hind legs were dissected and cultured in microtitre plates as described above.
Tissue explantation. Mice were killed with chloroform and tissue explantation was carried out immediately. Both hind feet were cleaned by washing with absolute alcohol, then a sliver of skin and subcutaneous tissue was excised from both FPs using separate sterile instruments. Each section of FP was dipped separately in 1 ml of absolute alcohol for about 20 s, dried on sterile tissue and placed in a separate microtitre plate well containing 0-1 ml of Eagle's medium with 50% foetal calf serum, containing penicillin, streptomycin and fungizone (EFC). Each section was divided into three, the fragments were placed into separate microtitre plate wells and 0.1 ml EFC was added. The dishes were incubated at 31 °C in a humidified incubator in an atmosphere of 5% CO2 in air.
Homogenization was carried out by placing the sliver of FP tissue into a sterile 1 ml glass homogenizer in 0.5 ml of EFC. The tissue was homogenized completely using l0 firm strokes of the plunger.
The lower two thoracic, the six lumbar and the first sacral DRG were dissected from the left and right sides. DRG were usually incubated individually in microtitre plate wells as previously described. In some cases ganglia from individual mice were pooled and dissociated with 1% coilagenase (Kennedy et al., 1983) ; then they were plated onto a semiconfluent 30 mm dish of C13 cells in CMRL-1066 (Gibeo) medium containing 2 mM-glutamine, 6 g/l glucose, 25 ~tg/ml gentamicin, 50% foetal calf serum with 5% human serum and incubated at 31 °C in an atmosphere of 5% CO 2 in air. After l0 days the plates were fixed and stained with Giemsa stain and plaques were counted.
Screening for virus releusedfrom DRG and FP. Medium from each individual microtitre well containing cultured tissue was screened daily for released virus. Medium was transferred to a separate well of a flat-bottomed microtitre plate containing a semi-confluent monolayer of Cl3 cells and incubated at 31 °C in a humidified incubator in an atmosphere of 5% CO 2 in air. Screening was carried out daily during the first 2 weeks after dissection, and subsequently twice weekly. The first screening always took place within 24 h following explantation.
Released virus in the supernatant was detected by the appearance ofa c.p.e, in the indicator C13 monolayer by the second or third day. Plates were examined and medium from individual wells with visible c.p.e, was added to a 30 mm Petri dish containing a semi-confluent monolayer of C 13 cells. The cells in the microtitre plate were then fixed and stained with Giemsa stain and subsequently scored for c.p.e, by examination using an inverted microscope. The infected cells in the 30 mm dishes were incubated at 31 °C until a confluent c.p.e, was seen. Remaining adherent cells were scraped off into the medium with a sterile policeman and the suspension was stored frozen at -70 °C.
Resistance to ACG. Virus released from latently infected mouse tissue was titrated in C13 cells and then assayed for resistance to ACG using a yield assay. Limbro wells were seeded with 1 x 105 C13 cells and incubated overnight. Six wells were then infected with each virus isolate at a m.o.i, of I p.f.u./cell. After absorption at 31 °C for 30 min all the supernatant was removed and Eagle's medium with 10~ calf serum was added with either no ACG or ACG at 1 gM, 3 ~tM, 10 gM, 30 ~tM or 60 ~. Cultures were incubated at 31 °C for 24 h and then harvested by scraping adherent cells into the supernatant. Supernatants were stored at -70 °C, subsequently sonicated and the yield of HSV was titrated on C13 cells at 31 °C using 10-fold dilutions. Sensitivity testing of FP isolates was always carried out in parallel with HG52, ts3 or ts4 and an ACG-resistant HG52 mutant ACG2321 isolated by Dr C. Crumpacker, Department of Medicine, Harvard Medical School, Boston, Mass., U.S.A. In addition, isolates from mice inoculated with ts virus were titrated at 31 °C and 38.5 °C.
RESULTS
Apart from some transient inflammation and swelling of the inoculated FP no evidence of illness was observed in any of the mice after virus inoculation. There was no evidence of recurrent disease suggestive of reactivation on examination with the naked eye.
Screening for infectious HSV in FP at the time of dissection
Both right and left FP tissue was dissected from one litter of six mice each inoculated with 1 x l0 s p.f.u, of wt HG52 into the right rear FP 3 months previously. One half FP from each mouse was homogenized and the homogenate inoculated onto a Petri dish of near confluent C 13 cells, the other half FP was cultured intact in a microtitre plate well with daily changing of medium. Spent medium was inoculated onto C 13 cells and after incubation for 3 days was fixed and examined for c.p.e. No c.p.e, was seen in the C13 cultures inoculated with FP homogenate and no toxicity was noted. However HSV was detected in the supernatant of four of the six half FPs from the right side cultured as tissue fragments, c.p.e, first being detected in medium removed on the 7th, 9th and in two cases on the 10th day after explantation. No virus was ever released from the FP taken from the left hand side, contralateral to the site of inoculation, confirming previous results (AI-Saadi et al., 1983; Subak-Sharpe et al., 1984a, b) .
The sensitivity of detection of HSV in the presence of homogenized FP tissue
The effect of homogenization of HSV-2 in the presence of FP tissue was investigated in reconstruction experiments by adding three different dilutions of HSV-2 HG52 to FP tissue either before or after homogenization (Table l) . The homogenate was then titrated in duplicate on plates of C 13 cells. No toxicity was observed in the C 13 cell cultures used for the titration nor was there any suggestion of loss of virus infectivity after homogenization and titration, in the presence of FP tissue.
FP tissue of ACG-treated mice
All mice treated with ACG behaved quite normally and showed no untoward effects. Table 2 shows recovery of virus from cultured mouse FP comparing untreated and ACG-treated groups. The overall results from the untreated animals were very similar to and confirmed those previously reported (A1- Saadi et al., 1983 ; Clements & Subak-Sharpe, 1983; Subak-Sharpe et al., 1984a, b) . In the control groups of mice not treated with ACG, 56~ of mice shed virus from the FP. ts4 was recovered from 78~o of the mice, wt virus from 43~ and ts3 from 67~o. FP cultures were scored as negative only after screening for at least 25 days after explantation. To avoid bias we excluded FPs that failed to release virus but had to be discarded prior to this time due to contamination. The average time to first detection of virus in the FP supernatant was 13 days in the case ofwt virus and between 14 and 19 days in the case of the ts mutants (Table 3 ). There was Overall, 75~o (49 of 65) of the ACG-treated mice shed virus from the FP, a figure significantly different (X 2, P < 0.05) from the control group in which 56~ of mice shed virus (Table 2) .
When recovery of ts3 and ts4 was examined independently of wt there was no significant difference between the control and ACG-treated groups but the numbers are very small. These results clearly indicate that the recovery of virus from the FP of ACG-treated mice is not less frequent than from untreated FP controls.
More prolonged treatment with ACG did not prevent recovery of virus from the FP. Each of three mice latently infected with HG52 and treated with ACG continuously in the drinking water for 6 months yielded virus from the FP after explantation and screening.
Throughout the studies every FP was divided into three fragments, which were screened independently; release of virus from the fragments was monitored on an individual basis. Table   4 gives a representative picture of the results obtained from two mice inoculated with ts4 that had been treated with ACG. There was clearly no spillover of virus between adjacent wells on the microtitre plate. Virus was recovered only from the right FP of each mouse. In the case of Table 4 .
Days after
Mouse 
HSV-2 latency in mouse footpad
379
Timing of reactivation of ts4 from the left and right FP of two mice treated with ACG*
* Each FP section was cut into three and the supernatant was screened for the release of virus; R, right; L, left. mouse A virus reactivation was detected from only one of the three right side fragments but it occurred during two separate essentially sequential periods: from day 15 to day 29 and day 56 to day 77. In the case of mouse B all three right-hand side FP fragments reactivated. In each case there was one sequence of four or five positive samples: days 15 to 29, days 29 to 38 and days 35 to 45. In our experiments virus released into the supernatant was usually detectable over a sequence of several successive samples after which supernatants reverted to being negative. A second positive period as shown with mouse A was only rarely observed. It is clear that reactivation took place independently within the separate fragments of each FP.
DRG tissue of ACG-treated mice
In addition to FP tissue, DRG from mice inoculated with wt virus were screened for reactivation of latent virus; 100 ~o of ACG-treated mice and 83 ~ of control mice shed virus from explanted DRG. In the case of the control group inoculated with ts3, two of three mice in which intact ganglia were screened released virus. For technical reasons the DRG from the remaining mice in this series (inoculated with ts3 and ts4) were dissociated before screening. Considerably more plaques were recovered from dissociated ganglia of mice inoculated with ts4 (eight plaques from 16 control mice and 46 plaques from 22 ACG-treated mice) than from mice inoculated with ts3 (no plaques from 11 control mice and two plaques from 17 ACG-treated mice). However the input dose of ts4 had been more than 10-fold higher than ts3. As expected ts3 reactivated less efficiently from DRG than from FP tissue (A1- Saadi et al., 1983) . The majority of mice inoculated with ts3 that reactivated virus from the FP could not have reactivated virus from ganglia: 17 of these mice shed virus from FP but only two plaques of virus were obtained from the DRG, both from mice treated with ACG. In keeping with our previous observations, reactivation of HSV from DRG and FP of individual mice was not correlated.
Nerve section A further group of mice was inoculated with 1 × 105 p.f.u, of HG52 and separated into four groups: (1) untreated control, (2) oral ACG as before (except that treatment continued until the time of dissection and the dose of ACG was increased to 1 mg/ml in the drinking water), (3) section of the femoral and sciatic nerves of the inoculated leg 7 days prior to dissection and (4) mock nerve section in which the skin was incised and the nerves exposed but not sectioned. Table 5 presents the results. In this experiment virtually all mice reactivated virus from their DRG. Virus reactivated from the FP in between 42% and 75 % of mice in the groups. There is no evidence that ACG treatment or nerve section prevented subsequent reactivation from the FP.
In a separate experiment a further group of mice inoculated with 1 x l0 s p.f.u, of HG52 was treated with ACG for 6 weeks and nerve section carried out prior to dissection. Of nine mice so treated seven released virus from DRG, and six released virus from FP (Table 5 ). Virus was released from both DRG and FP in five mice and from FP but not DRG in one mouse. In this series of experiments virus was first detected released from the DRG on day 6 following dissection and from the FP on day 17. Screening was continued for 59 days, the last DRG to become positive did so on day 38 and the last FP on day 28.
A CG sensitivity testing of viral isolates
HSV isolates obtained from FP and DRG of mice (both control and ACG-treated) were grown into stocks and screened for resistance to ACG. Of the 37 independent isolates examined from mice treated with ACG none differed significantly from wt virus in resistance to ACG. In addition 16 independent isolates from control mice were tested for ACG resistance. One of these isolates, obtained from a mouse inoculated with ts3, was ACG-resistant. Further examination of the wt HG52 virus stocks used shows the presence at a low frequency of pre-existing ACGresistant variants within the population (I. Acza, personal communication). All isolates from mice inoculated with ts virus remained ts.
DISCUSSION
We have previously reported recovery of HSV-1 and HSV-2 from the explanted skin of the FP at the site of inoculation 3 months or more after inoculation (A1- Saadi et al., 1983; Subak-Sharpe et al., 1984a, b) . The evidence for actual latency in cells located in the FP can be summarized as follows. Virus has never been recovered from latently infected mice when the FP tissue was homogenized immediately after explantation. Virus has been detected first in FP culture supernatant most commonly between 10 and 21 days after explantation but in a few cases it took much longer, up to the 45th day; the earliest that virus has been recovered from a FP culture has been on the 6th day. Reactivation of virus from DRG and FP in individual mice was not correlated: in some cases virus could be recovered from DRG but not FP, in others from FP but not DRG, in still others from both sites. Virus has never been recovered from the FP opposite to that inoculated.
The experiments reported here extend the evidence, by showing that neither ACG treatment, nor nerve section, nor ACG treatment and nerve section combined, prevent or even modify the recovery of HSV from the explanted FP. There are three different mechanisms that could be proposed to explain the presence of HSV within the mouse FP under these conditions: latency in (non-neuronal) cells permanently within the FP, persistence of the virus (continuously present and replicating slowly) within the FP, or 'classical' latency within cells of the DRG (or sympathetic or parasympathetic ganglion cells), coupled with the assumption that the virus must have reactivated shortly before death and entered the FP by travelling down the nerve fibre.
However, we have now shown that recovery of wt HSV-2 (HG52) and of ts mutants ts3 and ts4 from the explanted FP was not affected by prolonged prior treatment of the mice with ACG. Such ACG treatment would be expected to prevent both persistent infection of the ACGsensitive virus within the FP and also reactivation of such latent virus from DRG (the latter two mechanisms above). It has been demonstrated by others that supplying ACG in the drinking water is an effective method of presenting the drug to mice: they showed that cutaneous replication of HSV was suppressed after acute infection, but found no effect on an established latent infection in the DRG (Field & DeClerq, 1981) . It is well documented that established latent HSV infections in DRG are not eradicated by treatment with ACG (Field et al., 1979; Klein et al., 1979; Blyth et al., 1980) . ACG treatment prevents or reduces the establishment of latency only when given during the acute infection (Field et al., 1979; Klein et al., 1979; Park et al., 1979) . There remained the possibility of selective survival and establishment of ACGresistant virus in the mice during the course of the ACG treatment. However, this theoretical possibility received no experimental support, as none of the 37 independent isolates from ACGtreated mice proved to be ACG-resistant. In fact only one ACG-resistant isolate was recovered out of 53 independent tests, and that originated from a mouse not treated with ACG and was clearly a spontaneous mutant.
It is widely accepted that HSV may reactivate from latency in the DRG at any time before death and pass down axons to the periphery resulting in a recurrence. Spontaneous reactivation of latent HSV leading to visible lesions has been reported on rare occasions in mice after ear inoculation, but can be induced reproducibly by a variety of stimuli, e.g. stripping of the ear skin with cellophane tape (Hill et al., 1978) . However such induced recurrence is almost totally prevented by treatment with ACG . If reactivation from latency had taken place during life one would expect to be able to detect virus in FP tissue homogenized immediately after explantation in at least a proportion of cases. In fact virus could not be recovered from FP tissue homogenized immediately after removal, even though fragments of the same FP released virus after some days in culture. Reconstruction experiments (Table 1) show that homogenization of HSV with FP tissue does not lead to detectable loss of infectivity or reduce the probability of detection of infectious virus. Virus was never detected before the sixth day after explantation in this series of experiments and the mean time to first detection of virus ranged from 13 to 19.6 days; in some instances virus was first detected as late as 39 days after explantation (Table 3) . Moreover the time of initial virus recovery from different fragments of the same FP in most instances differs considerably. It seems to us entirely possible that in the mouse ear model of Hill et al. (1978) in which reactivation has clearly been demonstrated in vivo, the virus recovered from the ear may in fact derive from two sources. The most important source may be reactivation from DRG in vivo, which can be induced by cellophane stripping and is blocked by ACG; but there may well also exist a minority source which is latency in nonneuronal tissue within the mouse ear, analogous to the situation we find in the mouse footpad. If this is so, then our FP system differs in at least two ways: spontaneous reactivation from DRG has not been seen during life, and successful reactivation from latency within the explanted FP is more frequent. There may be intrinsic differences between the behaviour of the virus at the two peripheral inoculation sites. The differences found may also stem from use of different mouse and virus strains. Differences in the frequency of successful reactivation of latent virus from different strains of mice have been demonstrated (AI-Saadi et al., 1983) . Harbour et al. (1981) using the HSV-1 strain SC16 reported no erythema at the site of inoculation, the ear, 6 weeks after infection in BALB/c mice. With the other mouse strains used, from 2~ to 43~ of mice showed erythema at this time. In some mice this erythema could have been due to unresolved primary disease but in others it was considered to result from spontaneous recurrence of disease (Hill et al., 1978) . BALB/c mice also differed in another respect: virus could be reactivated from the site of inoculation by cellophane tape stripping only on the first occasion in outbred mice, but in outbred mice and the other inbred lines cellophane tape stripping also provoked reactivation on the second and subsequent occasions.
It is important that section of the femoral and sciatic nerves of the inoculated leg 1 week prior to dissection and explantation of the FP failed to prevent or to modify significantly HSV reactivation. Neuronal processes distal to the section including those in the FP would degenerate rapidly following nerve section and by the time of FP explantation would be nonviable and unable to act as a potential source from which latent virus could reactivate. Thus any possibility that HSV exists in a latent state within the nerve processes of the FP can be discounted. Some nerve fibres of the autonomic system to the FP may remain intact after nerve section, but their contribution to the innervation of the FP is very small and an explanation invoking their role as central would not be consistent with all the results.
When FP explants were cut in three and screened individually HSV reactivated from the individual fragments independently. In a proportion of cases virus was detected in all three fragments originating from the same FP. On at least two occasions virus was detected in the supernatant of the same explanted fragment during two separate sequential periods, with a break of some 2 weeks in between when the supernatants were negative. This is considered evidence of independent reactivation from separate sites of latency in the same fragment.
All explanted fragments from the left FP remained negative throughout. This implies that the latently infected FP cells are not mobile in vivo. Reactivation of virus from FP tissue and DRG of individual mice throughout our studies has been found to take place independently.
Taken together, all these findings provide compelling and entirely consistent evidence that HSV can exist in a truly latent state within cells in the mouse FP. The timing of first detection of virus in the supernatant of the explanted FP, though not precisely identifying the actual time of virus reactivation from the latent state, clearly demonstrates that an interval of many days and in some cases several weeks elapses before infectious virus is released from the tissue. We consider that during this period the process of reactivation takes place and that it may then be followed by virus replication within neighbouring cells in the explanted tissue until some infectious particles become released into the supernatant and detectable by the screening procedure.
Since neuronal cell bodies are not present within the footpad, latency of HSV here must be established in cells other than neurons. Direct evidence to that effect is beginning to be obtained: using in situ hybridization with HSV-specific probes viral RNA has been detected in a subpopulation of epithelial cells of the explanted FP (G. B. Clements & F. Jamieson, unpublished results) .
An important question is whether this mouse model of peripheral latency has some parallel to the situation that obtains in humans. There have been some reports of herpetic lesions appearing in denervated areas of human skin (Hoyt & Billson, 1976) but in general, attempts to recover latent HSV from peripheral sites of humans have been unsuccessful (Rustigian et al., 1966) . One exception has been reported recently: HSV has been isolated from human corneas removed prior to corneal transplantation for chronic stromal keratitis (Shimeld et al., 1982; Tullo et al., 1985 ; S. Cook, personal communication) . The timing of release of virus from corneal cultures is similar to that found for mouse FP tissue. In our view a general re-evaluation of the possibility of latency of HSV in non-neural sites in humans by current virological and molecular techniques is clearly necessary.
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